Lucideon, the international materials development and commercialization organisation, is pleased to announce that Leah Guenther has been appointed as the new commercial engineer for healthcare.
Stoke-on-Trent (UK), 23 August 2018 - Lucideon, the international materials development and commercialization organisation, is pleased to announce that Leah Guenther has been appointed as the new commercial engineer for healthcare.
Leah has an M.Sc. in Mechanical Engineering from the University of Manitoba in Winnipeg, Canada. She specialized in orthopaedic wear testing, focusing on the effect of lubricant composition on polyethylene wear.
As a commercial engineer, Leah will be the main point of contact for Lucideon’s orthopaedic clients. She will be on hand to provide expert insight and technical guidance for the development and regulatory testing of orthopaedic implants.
During her career, Leah has contributed to a number of implant retrieval studies, combining failure analysis techniques with clinical data in order to assess the performance and survivorship of joint replacement systems.
Leah said:
“I’m thrilled to be joining the Lucideon team. The team has a great energy and I’m looking forward to developing relationships with existing and new clients in the orthopaedic product development space.
“My new role will allow me to utilize my experience to help market leading manufacturers push the boundaries in orthopaedic implant development. I am excited to support their teams in creating great products that make a real difference in people’s lives.”
Lucideon Healthcare partners with clients across the globe to support their materials challenges throughout the lifecycle of their products. Through expert consultancy, technology development, and testing and characterization services, Lucideon Healthcare works as an extension to its clients’ teams, providing quicker routes to market, competitive advantage, regulatory approvals, and game-changing materials science. With technical expertise, industry experience, and analytical and materials know-how, Lucideon Healthcare works across a range of segments, including orthopaedics, vascular, dental, consumer healthcare, pharmaceutical, wound care, and medical devices.
Further information about Lucideon’s healthcare services please visit www.lucideon.com/lucideon-healthcare.
-ENDS-
About Lucideon
Lucideon is a development and commercialization organization (DCO), specializing in materials technologies and processes. Its application of cross-industry insight, materials science expertise and innovative thinking allows industry to develop and implement disruptive technology platforms, providing cost and/or product performance benefits and enabling real market differentiation. It utilizes its thousands of man years of experience in development, analysis and assurance to deliver significant competitive advantage to its customers.
In addition to a multi-disciplinary team of scientists, engineers and commercial analysts, Lucideon has world-leading testing and characterization laboratories, a combination of pilot and feasibility plant and equipment and a management and certification division.
Lucideon Group Limited has three subsidiaries: Lucideon Limited headquartered in the UK; Lucideon M&P headquartered in Raleigh, North Carolina, and Lucideon CICS, its assurance division. All subsidiaries do business as Lucideon.
For further information, please contact:
Daniel Minchin, Marketing Executive, Healthcare
Phone: +44 (0)1782 764402
Email: daniel.minchin@lucideon.com
